AmerisourceBergen comments on Trump Administration blueprint for lowering drug pricing

 
IPN and Besse Medical leadership submitted comments on Monday July 16, 2018, on behalf of AmerisourceBergen on over 150 concepts laid out by the HHS Secretary Azar to reduce Rx drug prices and improve affordability for patients.

Our comments focused on protecting the future of community physician practices:
  • Support for eliminating prohibition on pharmacists alerting consumers to lower cost Rx options (gag clauses)
  • Support for greater access and availability to biosimilars and generic products 
  • Oppose moving Medicare Part B drugs to Part D and reinstitution of Medicare Competitive Acquisition Program (CAP)
  • Support patient copayment assistance programs 
  • Support for value-based purchasing arrangements